Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration 4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (0.004-0.12), for SPNI was 0.03 µg/ml (0.004-025), for SPNR was 0.06 µg/ml (0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | Spanish / Castilian |
Published: |
Sociedad Médica de Santiago
2005
|
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000400004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0034-98872005000400004 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0034-988720050004000042005-06-13Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenosUlloa F,María TCamponovo C,RossannaFernández V,AlejandraGarcía C,PatriciaPrado J,ValeriaGonzález A,PatriciaRojas S,PamelaInostroza S,JaimeLafourcade R,MónicaAguilera A,LilianaPorte T,LorenaCruz P,CarolinaJoyas M,AlejandroAlcaide L,BertaPinto C,María EGiglio M,María S Bacterial sensitivity tests Ketolides Respiratory tract infections Telithromycin Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration 4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (0.004-0.12), for SPNI was 0.03 µg/ml (0.004-025), for SPNR was 0.06 µg/ml (0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infectionsinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.4 20052005-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000400004es10.4067/S0034-98872005000400004 |
institution |
SCIELO |
collection |
OJS |
country |
Chile |
countrycode |
CL |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-cl |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
Spanish / Castilian |
format |
Digital |
author |
Ulloa F,María T Camponovo C,Rossanna Fernández V,Alejandra García C,Patricia Prado J,Valeria González A,Patricia Rojas S,Pamela Inostroza S,Jaime Lafourcade R,Mónica Aguilera A,Liliana Porte T,Lorena Cruz P,Carolina Joyas M,Alejandro Alcaide L,Berta Pinto C,María E Giglio M,María S |
spellingShingle |
Ulloa F,María T Camponovo C,Rossanna Fernández V,Alejandra García C,Patricia Prado J,Valeria González A,Patricia Rojas S,Pamela Inostroza S,Jaime Lafourcade R,Mónica Aguilera A,Liliana Porte T,Lorena Cruz P,Carolina Joyas M,Alejandro Alcaide L,Berta Pinto C,María E Giglio M,María S Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
author_facet |
Ulloa F,María T Camponovo C,Rossanna Fernández V,Alejandra García C,Patricia Prado J,Valeria González A,Patricia Rojas S,Pamela Inostroza S,Jaime Lafourcade R,Mónica Aguilera A,Liliana Porte T,Lorena Cruz P,Carolina Joyas M,Alejandro Alcaide L,Berta Pinto C,María E Giglio M,María S |
author_sort |
Ulloa F,María T |
title |
Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
title_short |
Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
title_full |
Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
title_fullStr |
Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
title_full_unstemmed |
Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
title_sort |
estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos |
description |
Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration 4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (0.004-0.12), for SPNI was 0.03 µg/ml (0.004-025), for SPNR was 0.06 µg/ml (0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections |
publisher |
Sociedad Médica de Santiago |
publishDate |
2005 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000400004 |
work_keys_str_mv |
AT ulloafmariat estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT camponovocrossanna estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT fernandezvalejandra estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT garciacpatricia estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT pradojvaleria estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT gonzalezapatricia estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT rojasspamela estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT inostrozasjaime estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT lafourcadermonica estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT aguileraaliliana estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT portetlorena estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT cruzpcarolina estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT joyasmalejandro estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT alcaidelberta estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT pintocmariae estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos AT gigliommarias estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos |
_version_ |
1755988158970855424 |